ARTICLE | Company News
Avexa, Shire Pharmaceuticals Group plc deal
January 24, 2005 8:00 AM UTC
SHP granted AVX a license to SPD754, a cytidine analog nucleoside reverse transcriptase inhibitor (NRTI) to treat HIV. SPD754 has completed Phase IIa trials. Avexa is responsible for global developmen...